Quantessence Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$334K Buy
+440
New +$332K 1.67% 26

Other funds holding REGN

Quantessence Capital's REGN Position: Q3 2026 in Review

Quantessence Capital opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 440 shares worth $334K. The stake represents 1.67% of the portfolio and ranks #26 among its holdings.

1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Quantessence Capital held 440 shares of Regeneron Pharmaceuticals worth $334K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Quantessence Capital position in Q3 2026.
  • Regeneron Pharmaceuticals made up 1.67% of Quantessence Capital's portfolio in Q3 2026, its #26 holding.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Quantessence Capital's 13F filing for Q3 2026, filed 16 Nov 2026.